stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Operating cash flow
Teleflex Incorporated's operating cash flow for fiscal 2025 was $96.7M, down 68.0% from $301.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was $129.3M. Over the past ten years it has ranged from $96.7M (fiscal 2025) to $652.1M (fiscal 2021) — the current reading is the lowest in ten years. Teleflex Incorporated ranks 21st of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $96.7M | (67.97%) |
| FY2024 | $301.9M | 46.45% |
| FY2023 | $206.1M | (39.87%) |
| FY2022 | $342.8M | (47.43%) |
| FY2021 | $652.1M | 49.18% |
| FY2020 | $437.1M | 0.02% |
| FY2019 | $437.1M | 0.46% |
| FY2018 | $435.1M | 2.06% |
| FY2017 | $426.3M | 3.83% |
| FY2016 | $410.6M | 35.31% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $91.9M | 96.94% |
| Mar 2026 | $46.7M | — |
| Jun 2025 | −$37.0M | — |
| Mar 2025 | $27.7M | (88.00%) |
| 39 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| AVTR Avantor, Inc. compare | $584.7M |
| ATR AptarGroup, Inc. compare | $573.5M |
| BLCO Bausch + Lomb Corporation compare | $554.0M |
| NVST Envista Holdings Corporation compare | $301.8M |
| ICUI ICU Medical, Inc. compare | $279.2M |
| MMSI Merit Medical Systems, Inc. compare | $273.7M |
| TFX Teleflex Incorporated | $129.3M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| MMED MiniMed Group, Inc. compare | −$134.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement